Latest filing published 28 Nov 2011 for ROCK CREEK PHARMACEUTICALS, INC., €103k.
Filing timeline
BuySaleFirst 200 filings with a declared amount
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +104.4%Entry US$13.70 · Close at T+365 US$28.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Richard L. Sharp: trading record in brief
Richard L. Sharp is a declared insider at 4 companies; the most frequent names are Crocs, Inc., Flex Ltd. and Rock Creek Pharmaceuticals, Inc. In total, 228 filings cover trades dated from 3 January 2006 to 28 November 2011.
Market trades split into 5 purchases (€3.7M) and 196 sales (€52.9M). The net balance comes to €49.2M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 14 share grants and 5 option exercises. In 2011 alone, the filings show 3 purchases and 6 sales.
Half of the purchases are above €103k and half below.
The latest filing, published on 28 November 2011, reports an open-market purchase of €35k in Rock Creek Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Richard L. Sharp
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 59,500 shares@ US$2.33Common StockSEC:0001209191-11-058110:0Canonical exit: 21 Feb 2012 (T+90)
- 17,972 shares@ US$2.56Common StockSEC:0001209191-11-058110:1Canonical exit: 23 Feb 2012 (T+90)
- 22,528 shares@ US$2.63Common StockSEC:0001209191-11-058110:2Canonical exit: 26 Feb 2012 (T+90)
- 7,797 shares0Common StockSEC:0001181431-11-039423:0
- 152,713 shares@ US$1.69Common StockSEC:0001181431-11-028658:0
- 152,713 shares@ US$21.00Common StockSEC:0001181431-11-028658:1
- 39,610 shares@ US$21.06Common StockSEC:0001181431-11-028658:2
- 39,610 shares@ US$21.04Common StockSEC:0001181431-11-028658:3
- 39,610 shares@ US$21.01Common StockSEC:0001181431-11-028658:4
- 39,600 shares@ US$21.01Common StockSEC:0001181431-11-028658:5
- 197,717 shares@ US$1.69Common StockSEC:0001181431-11-028658:6
- 197,717 shares@ US$21.03Common StockSEC:0001181431-11-028658:7
- 63,800 shares@ US$13.19Common StockSEC:0001181431-10-043310:0
- 31,700 shares@ US$13.48Common StockSEC:0001181431-10-042761:0
- 31,954 shares@ US$13.48Common StockSEC:0001181431-10-042761:1
- 33,200 shares@ US$13.48Common StockSEC:0001181431-10-042761:2
- 30,039 shares@ US$13.48Common StockSEC:0001181431-10-042761:3
- 160,900 shares@ US$13.31Common StockSEC:0001181431-10-042761:4
- 16,300 shares@ US$13.19Common StockSEC:0001181431-10-042761:5
- 16,046 shares@ US$13.19Common StockSEC:0001181431-10-042761:6
- 14,800 shares@ US$13.19Common StockSEC:0001181431-10-042761:7
- 17,961 shares@ US$13.20Common StockSEC:0001181431-10-042761:8
- 9,337 shares0Common StockSEC:0001181431-10-035646:0
- 9,804 shares0Common StockSEC:0001181431-10-035646:1
- 39,216 sharesCommon StockSEC:0001181431-09-032678:0
25 of 224 declarations
